Lumos Pharma, Inc. (NASDAQ:LUMO) Q4 2023 Earnings Call Transcript March 7, 2024
Lumos Pharma, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here).
Operator: Good afternoon and welcome to Lumos Pharma’s 2023 Fourth Quarter and Year End Conference Call. Currently all participants are on a listen-only mode. Later we will conduct a question-and-answer session and instructions will follow at that time. As a reminder, this...
